140 related articles for article (PubMed ID: 9057654)
1. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells.
Stetler-Stevenson M; Mansoor A; Lim M; Fukushima P; Kehrl J; Marti G; Ptaszynski K; Wang J; Stetler-Stevenson WG
Blood; 1997 Mar; 89(5):1708-15. PubMed ID: 9057654
[TBL] [Abstract][Full Text] [Related]
2. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.
Kossakowska AE; Urbanski SJ; Watson A; Hayden LJ; Edwards DR
Oncol Res; 1993; 5(1):19-28. PubMed ID: 8369572
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
4. Human T lymphocytes synthesize the 92 kDa type IV collagenase (gelatinase B).
Weeks BS; Schnaper HW; Handy M; Holloway E; Kleinman HK
J Cell Physiol; 1993 Dec; 157(3):644-9. PubMed ID: 8253876
[TBL] [Abstract][Full Text] [Related]
5. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells.
Fabunmi RP; Baker AH; Murray EJ; Booth RF; Newby AC
Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):335-42. PubMed ID: 8670128
[TBL] [Abstract][Full Text] [Related]
6. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
[TBL] [Abstract][Full Text] [Related]
7. Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas.
Iwata H; Kobayashi S; Iwase H; Masaoka A; Fujimoto N; Okada Y
Jpn J Cancer Res; 1996 Jun; 87(6):602-11. PubMed ID: 8766524
[TBL] [Abstract][Full Text] [Related]
8. Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells.
Cha HJ; Bae SK; Lee HY; Lee OH; Sato H; Seiki M; Park BC; Kim KW
Cancer Res; 1996 May; 56(10):2281-4. PubMed ID: 8625299
[TBL] [Abstract][Full Text] [Related]
9. Timp-1, -2 and -3 show coexpression with gelatinases A and B during mouse tooth morphogenesis.
Sahlberg C; Reponen P; Tryggvason K; Thesleff I
Eur J Oral Sci; 1999 Apr; 107(2):121-30. PubMed ID: 10232461
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta.
Tamarina NA; McMillan WD; Shively VP; Pearce WH
Surgery; 1997 Aug; 122(2):264-71; discussion 271-2. PubMed ID: 9288131
[TBL] [Abstract][Full Text] [Related]
12. Cytokine regulation of the matrix metalloproteinases and their inhibitors in human papillomavirus-18 transformed human prostatic tumor cell lines.
Wang M; Fudge K; Rhim JS; Stearns ME
Oncol Res; 1996; 8(7-8):303-15. PubMed ID: 8938794
[TBL] [Abstract][Full Text] [Related]
13. Expression of gelatinases A and B and their tissue inhibitors by cells of early and term human placenta and gestational endometrium.
Polette M; Nawrocki B; Pintiaux A; Massenat C; Maquoi E; Volders L; Schaaps JP; Birembaut P; Foidart JM
Lab Invest; 1994 Dec; 71(6):838-46. PubMed ID: 7807965
[TBL] [Abstract][Full Text] [Related]
14. Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements.
Yokohama Y; Matsumoto T; Hirakawa M; Kuroki Y; Fujimoto N; Imai K; Okada Y
Lab Invest; 1995 Dec; 73(6):899-911. PubMed ID: 8558853
[TBL] [Abstract][Full Text] [Related]
15. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas.
Airola K; Karonen T; Vaalamo M; Lehti K; Lohi J; Kariniemi AL; Keski-Oja J; Saarialho-Kere UK
Br J Cancer; 1999 May; 80(5-6):733-43. PubMed ID: 10360651
[TBL] [Abstract][Full Text] [Related]
16. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
[TBL] [Abstract][Full Text] [Related]
17. Co-expression of tissue inhibitor and matrix metalloproteinase in myocardium.
Tyagi SC; Kumar SG; Banks J; Fortson W
J Mol Cell Cardiol; 1995 Oct; 27(10):2177-89. PubMed ID: 8576934
[TBL] [Abstract][Full Text] [Related]
18. Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix.
Nakagawa T; Kubota T; Kabuto M; Fujimoto N; Okada Y
J Neurooncol; 1996 Apr; 28(1):13-24. PubMed ID: 8740587
[TBL] [Abstract][Full Text] [Related]
19. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors.
Nakagawa T; Kubota T; Kabuto M; Sato K; Kawano H; Hayakawa T; Okada Y
J Neurosurg; 1994 Jul; 81(1):69-77. PubMed ID: 8207529
[TBL] [Abstract][Full Text] [Related]
20. Studies on the effects of laminin, E-8 fragment of laminin and synthetic laminin peptides PA22-2 and YIGSR on matrix metalloproteinases and tissue inhibitor of metalloproteinase expression.
Mackay AR; Gomez DE; Nason AM; Thorgeirsson UP
Lab Invest; 1994 Jun; 70(6):800-6. PubMed ID: 8015284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
